5hon MSN
TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches
Discover TriSalus Life Sciences' Q3 2025 earnings: 57% revenue growth, new product launches, and a reaffirmed 50% growth outlook.
TriSalus Life Sciences Inc (TLSI) reports a 57% revenue increase, expands its product portfolio, and navigates challenges in manufacturing and reimbursement.
There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a ...
News-Medical.Net on MSN
Machine learning model boosts success of liver transplants from circulatory death donors
There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a ...
We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback